Brian Mills

Brian Mills, PhD, joined Pivotal Life Sciences in 2022. Prior to Pivotal, he was a research analyst at Jefferies covering the biotechnology sector, with a focus on neuroscience, psychiatry, precision medicine, IBD, microbiome, and orphan disease. His work integrated computational tools to derive insights into the space. Prior to Jefferies, Brian was a postdoctoral scholar at Stanford University where he studied neurological disease, including Alzheimer’s disease, Huntington’s disease, chronic fatigue syndrome, and traumatic brain injury. His PhD focused on developing translational biomarkers linking clinical and pre-clinical models of developmental disorders, including Autism and ADHD. He earned his PhD in neuroscience from Oregon Health and Science University (OHSU) and has published over 20 peer reviewed articles in top journals including the Journal of Neuroscience and PNAS.